Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2012) | Total Docs. (3years) | Total Refs. (2012) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2012) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Journal of Experimental Pharmacology | journal | 0.121 Q4 | 23 | 2 | 1 | 192 | 0 | 1 | 0.00 | 96.00 |  |
| 2 | Pharmacogenomics and Personalized Medicine | journal | 0.150 Q4 | 37 | 11 | 31 | 914 | 13 | 31 | 0.55 | 83.09 | |
| 3 | Clinical Medicine Insights: Therapeutics | journal | 0.109 Q4 | 11 | 22 | 83 | 1600 | 14 | 83 | 0.17 | 72.73 | |
| 4 | Core Evidence (discontinued) | journal | 0.725 Q2 | 29 | 12 | 38 | 757 | 102 | 36 | 2.41 | 63.08 | |
| 5 | Diabetes, Metabolic Syndrome and Obesity | journal | 0.447 Q3 | 64 | 42 | 51 | 2393 | 84 | 50 | 2.28 | 56.98 | |
| 6 | Drug, Healthcare and Patient Safety | journal | 0.375 Q3 | 30 | 17 | 51 | 826 | 64 | 49 | 1.22 | 48.59 | |
| 7 | Infection and Drug Resistance | journal | 0.614 Q2 | 65 | 20 | 33 | 953 | 63 | 31 | 2.07 | 47.65 | |
| 8 | Biomarker Insights | journal | 0.648 Q2 | 40 | 16 | 53 | 759 | 128 | 53 | 2.47 | 47.44 | |
| 9 | Drug Design, Development and Therapy | journal | 1.089 Q1 | 94 | 43 | 93 | 1938 | 437 | 93 | 5.24 | 45.07 | |
| 10 | Journal of Receptor, Ligand and Channel Research | journal | 0.676 Q2 | 13 | 2 | 10 | 44 | 25 | 9 | 2.50 | 22.00 | |
| 11 | Perspectives in Medicinal Chemistry | journal | 0.382 Q3 | 17 | 0 | 8 | 0 | 13 | 8 | 0.60 | 0.00 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data